Authors:
ALBINI A
FERRINI S
BENELLI R
SFORZINI S
GIUNCIUGLIO D
ALUIGI MG
PROUDFOOT AEI
ALOUANI S
WELLS TNC
MARIANI G
RABIN RL
FARBER JM
NOONAN DM
Citation: A. Albini et al., HIV-1 TAT PROTEIN MIMICRY OF CHEMOKINES, Proceedings of the National Academy of Sciences of the United Statesof America, 95(22), 1998, pp. 13153-13158
Authors:
SFORZINI S
DETOTERO D
GAGGERO A
IPPOLITI R
GLENNIE MJ
CANEVARI S
STEIN H
FERRINI S
Citation: S. Sforzini et al., TARGETING OF SAPORIN TO HODGKINS LYMPHOMA-CELLS BY ANTI-CD30 AND ANTI-CD25 BISPECIFIC ANTIBODIES, British Journal of Haematology, 102(4), 1998, pp. 1061-1068
Authors:
MEAZZA R
GAGGERO A
NEGLIA F
BASSO S
SFORZINI S
PERENO R
AZZARONE B
FERRINI S
Citation: R. Meazza et al., EXPRESSION OF 2 INTERLEUKIN-15 MESSENGER-RNA ISOFORMS IN HUMAN TUMORSDOES NOT CORRELATE WITH SECRETION - ROLE OF DIFFERENT SIGNAL PEPTIDES, European Journal of Immunology, 27(5), 1997, pp. 1049-1054
Authors:
REDAELLI B
LOCATELLI F
LIMIDO D
ANDRULLI S
SIGNORINI MG
SFORZINI S
BONOLDI L
VINCENTI A
CERUTTI S
ORLANDINI G
Citation: B. Redaelli et al., EFFECT OF A NEW MODEL OF HEMODIALYSIS POTASSIUM REMOVAL ON THE CONTROL OF VENTRICULAR ARRHYTHMIAS, Kidney international, 50(2), 1996, pp. 609-617
Authors:
MEAZZA R
MARCIANO S
SFORZINI S
ORENGO AM
COPPOLECCHIA M
MUSIANI P
ARDIZZONI A
SANTI L
AZZARONE B
FERRINI S
Citation: R. Meazza et al., ANALYSIS OF IL-2 RECEPTOR EXPRESSION AND OF THE BIOLOGICAL EFFECTS OFIL-2 GENE TRANSFECTION IN SMALL-CELL LUNG-CANCER, British Journal of Cancer, 74(5), 1996, pp. 788-795
Authors:
CAMBIAGGI A
ORENGO AM
MEAZZA R
SFORZINI S
TAZZARI PL
LAURIA F
RASPADORI D
ZAMBELLO R
SEMENZATO G
MORETTA L
FERRINI S
Citation: A. Cambiaggi et al., THE NATURAL KILLER-RELATED RECEPTOR FOR HLA-C EXPRESSED ON T-CELLS FROM CD3(+) LYMPHOPROLIFERATIVE DISEASE OF GRANULAR LYMPHOCYTES DISPLAYSEITHER INHIBITORY OR STIMULATORY FUNCTION, Blood, 87(6), 1996, pp. 2369-2375
Authors:
MEAZZA R
MARCIANO S
COPPOLECCHIA M
BIASSANI R
SFORZINI S
ORENGO AM
ARDIZZONI A
AZZARONE B
FERRINI S
Citation: R. Meazza et al., BIOLOGICAL CHARACTERISTICS OF SMALL-CELL LUNG-CANCER (SCLC) CELLS TRANSFECTED WITH HUMAN IL-2 GENE, European journal of cancer, 31A, 1995, pp. 1276-1276
Authors:
FAVONI RE
DECUPIS A
PERROTTA A
SFORZINI S
AMOROSO D
PENSA F
MIGLIETTA L
Citation: Re. Favoni et al., INSULIN-LIKE-GROWTH-FACTOR-I (IGF-I) AND IGF-BINDING PROTEINS BLOOD-SERUM LEVELS IN WOMEN WITH EARLY-STAGE AND LATE-STAGE BREAST-CANCER - MUTUAL RELATIONSHIP AND POSSIBLE CORRELATIONS WITH PATIENTS HORMONAL STATUS, Journal of cancer research and clinical oncology, 121(11), 1995, pp. 674-682
Authors:
SFORZINI S
BOLOGNESI A
MEAZZA R
MARCIANO S
CASALINI P
DURKOP H
TAZZARI PL
STEIN H
STIRPE F
FERRINI S
Citation: S. Sforzini et al., DIFFERENTIAL SENSITIVITY OF CD30(-CELLS TO GELONIN DELIVERED BY ANTI-CD30() NEOPLASTIC)ANTI-GELONIN BISPECIFIC ANTIBODIES/, British Journal of Haematology, 90(3), 1995, pp. 572-577
Authors:
NEGRI DRM
TOSI E
VALOTA O
FERRINI S
CAMBIAGGI A
SFORZINI S
SILVANI A
RUFFINI PA
COLNAGHI MI
CANEVARI S
Citation: Drm. Negri et al., IN-VITRO AND IN-VIVO STABILITY AND ANTITUMOR EFFICACY OF AN ANTI-EGFRANTI-CD3 F(AB')(2) BISPECIFIC MONOCLONAL-ANTIBODY, British Journal of Cancer, 72(4), 1995, pp. 928-933
Authors:
CANTONI C
CAMBIAGGI A
SFORZINI S
POGGI A
VIALE M
BIASSONI R
FERRINI S
Citation: C. Cantoni et al., CHARACTERIZATION OF A CYCLOSPORINE A-SENSITIVE ACTIVATION PATHWAY IN CULTURED-T AND NATURAL-KILLER-CELLS, Scandinavian journal of immunology, 39(4), 1994, pp. 373-379
Authors:
FERRINI S
SFORZINI S
CAMBIAGGI A
POGGI A
MEAZZA R
CANEVARI S
COLNAGHI MI
MORETTA L
Citation: S. Ferrini et al., THE LFA-1 ICAM CELL-ADHESION PATHWAY IS INVOLVED IN TUMOR-CELL LYSIS MEDIATED BY BISPECIFIC MONOCLONAL-ANTIBODY-TARGETED T-LYMPHOCYTES/, International journal of cancer, 56(6), 1994, pp. 846-852
Authors:
FERRINI S
CAMBIAGGI A
MEAZZA R
SFORZINI S
MARCIANO S
MINGARI MC
MORETTA L
Citation: S. Ferrini et al., T-CELL CLONES EXPRESSING THE NATURAL-KILLER CELL-RELATED P58 RECEPTORMOLECULE DISPLAY HETEROGENEITY IN PHENOTYPIC PROPERTIES AND P58 FUNCTION, European Journal of Immunology, 24(10), 1994, pp. 2294-2298
Authors:
FERRINI S
CAMBIAGGI A
SFORZINI S
CANEVARI S
MEZZANZANICA D
COLNAGHI MI
MORETTA L
Citation: S. Ferrini et al., USE OF ANTI-CD3 AND ANTI-CD16 BISPECIFIC MONOCLONAL-ANTIBODIES FOR THE TARGETING OF T-CELLS AND NK CELLS AGAINST TUMOR-CELLS, Cancer detection and prevention, 17(2), 1993, pp. 295-300
Authors:
FERRINI S
CAMBIAGGI A
SFORZINI S
MARCIANO S
CANEVARI S
MEZZANZANICA D
COLNAGHI MI
GROSSI CE
MORETTA L
Citation: S. Ferrini et al., TARGETING OF T-LYMPHOCYTES AGAINST EGF-RECEPTOR(-CELLS BY BISPECIFIC MONOCLONAL-ANTIBODIES - REQUIREMENT OF CD3 MOLECULE CROSS-LINKING FOR T-CELL ACTIVATION() TUMOR), International journal of cancer, 55(6), 1993, pp. 931-937
Authors:
TAZZARI PL
ZHANG S
CHEN Q
SFORZINI S
BOLOGNESI A
STIRPE F
XIE H
MORETTA A
FERRINI S
Citation: Pl. Tazzari et al., TARGETING OF SAPORIN TO CD25-POSITIVE NORMAL AND NEOPLASTIC LYMPHOCYTES BY AN ANTI-SAPORIN ANTI-CD25 BISPECIFIC MONOCLONAL-ANTIBODY - INVITRO EVALUATION, British Journal of Cancer, 67(6), 1993, pp. 1248-1253